Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Schram

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|November 6, 2015
Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 yearsAlison M Schram, Paige Comstock, Meghan Campo, et al.
British Journal of Cancer|November 15, 2018
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumoursAlison M Schram, Leena Gandhi, Monica M Mita, et al.
Oncotargets and Therapy|April 25, 2017
The activity, safety, and evolving role of brigatinib in patients with <i>ALK</i>-rearranged non-small cell lung cancersJoshua K Sabari, Fernando C Santini, Alison M Schram, et al.
JCO Precision Oncology|September 11, 2020
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid TumorsEzra Y Rosen, Alison M Schram, Robert J Young, et al.
JCO Precision Oncology|September 27, 2021
Spectrum of <i>BRAF</i> Mutations and Gene Rearrangements in Ovarian Serous CarcinomaM Herman Chui, Jason C Chang, Yanming Zhang, et al.
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
The Oncologist|August 2, 2023
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid TumorsElena Garralda, Alison M Schram, Philippe L Bedard, et al.
Cancer Discovery|December 2, 2025
Reflections on Advances in Cancer Research in 2025Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Journal of the National Cancer Institute|December 14, 2025
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancerAlison M Schram, Soo-Ryum Yang, Genessa Kahn, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|November 6, 2015
Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 yearsAlison M Schram, Paige Comstock, Meghan Campo, et al.
British Journal of Cancer|November 15, 2018
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumoursAlison M Schram, Leena Gandhi, Monica M Mita, et al.
Oncotargets and Therapy|April 25, 2017
The activity, safety, and evolving role of brigatinib in patients with <i>ALK</i>-rearranged non-small cell lung cancersJoshua K Sabari, Fernando C Santini, Alison M Schram, et al.
JCO Precision Oncology|September 11, 2020
Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid TumorsEzra Y Rosen, Alison M Schram, Robert J Young, et al.
JCO Precision Oncology|September 27, 2021
Spectrum of <i>BRAF</i> Mutations and Gene Rearrangements in Ovarian Serous CarcinomaM Herman Chui, Jason C Chang, Yanming Zhang, et al.
Ophthalmology. Retina|June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated RetinopathyJasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
The Oncologist|August 2, 2023
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid TumorsElena Garralda, Alison M Schram, Philippe L Bedard, et al.
Cancer Discovery|December 2, 2025
Reflections on Advances in Cancer Research in 2025Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Journal of the National Cancer Institute|December 14, 2025
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancerAlison M Schram, Soo-Ryum Yang, Genessa Kahn, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Pageof 8